Bayer AG will invest $2.2 billion to build a new pharmaceutical manufacturing site in New Albany, Ohio—part of its long-term growth and innovation strategy—building on more than $7 billion the company has spent on U.S. pharma R&D and manufacturing over the past five years.
Bayer AG (Leverkusen, Germany) announced plans to invest $2.2 billion in a new pharmaceutical manufacturing site in New Albany, Ohio. Building on more than $7 billion in U.S. pharma R&D and manufacturing spend over the past five years, the project is a central element of Bayer’s long-term growth strategy and commitment to innovation and patient […]
The post Bayer to construct new pharmaceutical manufacturing site in Ohio appeared first on Chemical Engineering.
Login to comment
Login0 Replies
0 Replies
1 Replies
2 Replies
0 Replies
0 Replies
0 Replies
0 Replies
0 Replies
0 Replies
0 Replies
0 Replies
0 Replies
0 Replies
0 Replies